Özdemir, Berna C (2021). Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology. Journal for immunotherapy of cancer, 9(2) BMJ Publishing Group 10.1136/jitc-2020-002220
|
Text
jitc-2020-002220.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (180kB) | Preview |
Despite a significant amount of data on incidence and therapy of immune-related adverse events affecting virtually all organ systems, the potential impact of immune checkpoint inhibitors (ICIs) on gonadal function has not been sufficiently studied. The limited evidence available suggests that ICI-related primary hypogonadism due to orchitis as well as secondary hypogonadism due to hypophysitis are a potential risk for infertility. A systematic investigation of gonadal function under ICIs is warranted given the increasing application of ICIs in the adjuvant setting, among young adults and children and the possible influence of sex hormone levels on the efficacy and toxicity of ICIs.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Özdemir, Berna |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2051-1426 |
Publisher: |
BMJ Publishing Group |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
24 Nov 2021 16:57 |
Last Modified: |
05 Dec 2022 15:54 |
Publisher DOI: |
10.1136/jitc-2020-002220 |
PubMed ID: |
33589529 |
Uncontrolled Keywords: |
immunotherapy |
BORIS DOI: |
10.48350/160866 |
URI: |
https://boris.unibe.ch/id/eprint/160866 |
Actions (login required)
 |
Edit item |